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Abstract
As one of the disciplines of systems biology, proteomics is central to enabling the elucidation of protein function
within the cell; furthermore, the question of how to deduce protein structure and function from the genetic read-
out has gained new significance. This problem is of particular relevance for proteins engaged in cell signalling. In
dealing with this question, I shall critically comment on the reliability and predictability of transmission and transla-
tion of the genetic blue print into the phenotype, the protein. Based on this information, I will then evaluate the
intentions and goals of today’s proteomics and gene-networking and appraise their chances of success. Some of
the themes commented on in this publication are explored in greater detail with particular emphasis on the histor-
ical roots of concepts and techniques in my forthcoming book, published in German: Von Molekülen zu Zellen. 100
Jahre experimentelle Biologie. Betrachtungen eines Biochemikers.
Introduction
The formation of functional proteins in the cell depends
on the reliable transcription and translation of the
genetic information. Today, genetics aims at describing
the functional correlate of the genome in the context of
the living cell, in other words, it tries to build a bridge
from genotype to phenotype. In classical genetics how-
ever, a gene was an abstract concept, a materially unde-
fined entity that ferried a characteristic property from
parent to offspring. Later, genes became chemically,
structurally and functionally defined RNA or DNA poly-
mers, [1], and chromosomes, where the genes are
located in the cell, were shown to be tightly packed pro-
tein-ribonucleic acid complexes, containing a linear
array of genes [2]. Finally, the syntax, the genetic mes-
sage, was deciphered and shown to consist of words
consisting of three letter syllables. Today, the question,
what is a gene and how does it function [3] must be
raised anew, a question that in the not too distant past
would have seemed silly, because every schoolchild
believed to know what a gene is. The root cause for this
confidence came from the organisation of the genome
in prokaryotes, where the gene and the product of its
transcription, the mRNA, and the product of its transla-
tion, the resulting protein’s amino acid sequence, were
seen to be co-linear. This assumption was experimen-
tally verified [4]. It also led to euphoric expectations in
human genetics. After the human genome had been
deciphered, the hope was to replace a diseased gene
with a functional one, bringing, at the very least, the
expectation of curing monogenetically-caused diseases.
Co-linearity in prokaryotes is possible, because tran-
scription and translation are not separated by cell com-
partmentalisation, as is the case for eukaryotes. In
prokaryotes, the nascent genetic readout, the mRNA,
binds directly to ribosomes where it is translated into
protein. However, due to the spatial separation of genes
and ribosomes, direct coupling of gene transcription,
translation and protein biosynthesis is no longer possible
in Eukarya. Whereas gene expression is confined to the
nucleus, translation is an exclusively cytoplasmic event.
Although separation of both processes makes gene
expression much more complicated than in bacteria, it
enabled the evolution of split genes and pre-messenger
RNA splicing in Eukarya, which in turn led to a massive
diversification of genetic information [5,6]. This, how-
ever, is only one of the key aspects that have profoundly
changed our views. Most recently, advances in genetics
have led to the comprehensive knowledge of the
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regulatory role of the products of the non-coding DNA,
the micro RNAs [7,8].
After the gene was shown to be composed of DNA,
[9,10], its structure solved by Watson and Crick, [11,12],
and its replication verified by Meselson and Stahl, [13],
the next question that had to be answered was, how is
the information in DNA transcribed and translated into
the language of proteins? The direction of the search
was set by Francis Crick’s brilliant idea of a unidirec-
tional path, DNA® RNA® Protein. Crick had suggested
that ’...the main function of the genetic material, DNA, in
a cell is to control, but not necessarily to direct the
synthesis of proteins...’ thus hinting at a role of mole-
cules, other than DNA, in protein synthesis. Moreover,
on the same occasion [14], he pronounced his central
dogma: ’... once information has passed from the nucleic
acids into protein, it can not get out again, only transfer
from nucleic acid to nucleic acid or from nucleic acid to
protein is possible.... (Citation from: Horace Freeland
Judson’s book, The eight day of creation. Makers of the
revolution in Biology” [15]). Crick’s dogma was a mod-
ern version of August Weismann’s [16] in which the
’Keimplasma’, containing the genes, was described as
being separate from the cell soma, which contained
everything else. A unidirectional transfer of information
from DNA to protein would also have forestalled any
kind of environmental influence on the gene, as
Lamarck had envisioned, because proteins are the agents
that communicate with the environment. While Crick’s
idea laid the foundations for the identification and char-
acterization of the instruments of gene transcription and
translation, tRNAs and mRNAs, and while he was right
on transfer only from nucleic acid to nucleic acid, the
idea of an unidirectional transfer of information, like
any other dogma in biochemistry, was short lived. After
Howard Temin [17] and David Baltimore [18] indepen-
dently discovered reverse transcription from RNA to
DNA, Crick’s paradigm had to be abandoned.
A focal point of my discussion of the route from gene
to protein is the plasticity of structure and function of
some proteins, notably of antibodies and receptors [19]
which allows one and the same protein to assume dif-
ferent structures and functions in the same cellular
environment. I shall give examples of pliable and
adaptable proteins and shall cite possible causes of
ligand-induced malleability of proteins. Finally, I shall
comment briefly on the revolutionary progress made in
recent years in the design and improvement of new and
old techniques respectively in vivo observations,
advances that give me confidence that the ambitious
goals of the in vivo 21
st century biochemistry might be,
at least in part, realized.
Comments
The genetics of today
The existence of split genes [20] was demonstrated by
Richard J. Roberts und Philip A. Sharp [21]: Within
exons, genomic regions containing coding sequences
which are transcribed and translated into defined pro-
tein products, are embedded what were initially thought
to be non-coding regions or introns. The splicing pro-
cess leads to removal of the introns, and the remaining
exons are fused and transcribed. Such a spliced gene
may have contained many introns ranging from 40 to
100,000 nucleotides in length. Transcription of spliced
genes results in a split RNA transcript. In the 1980s
Thomas Cech and his colleagues observed that the pro-
cessing and splicing of a 400 nucleotide long intron of
the ribosomal RNA of Tetrahymena thermophila did
not require any added proteins [22], leading to the con-
clusion that RNA itself can carry out splicing of its own
RNA. The RNA of Tetrahymena is a ribozyme [23].
Splicing of ribosomal RNA, or rRNA, and splicing of
pre-mRNA, are two different processes [1]. Removal of
introns of pre-mRNAs and ligation of the remaining
exons is executed by a nuclear machinery, the spliceo-
some. The spliceosome assembles itself anew on each
intron of a mRNA that requires splicing. Consisting of
four different, small nuclear ribonucleoproteins
(snRNPs), and 100-150 additional proteins, the spliceo-
some constitutes one of the most complex cellular
macromolecular machines identified to date.
Most mRNAs encoding more than one different
protein can be spliced by the spliceosome in a manner,
also known as alternative splicing, that ensures that dif-
ferent proteins can be generated from a single pre-
mRNA. In this way, splicing contributes to the efficient
and exhaustive use of the genetic repertoire and has
thus been instrumental in facilitating the evolutionary
process within organisms.
Alternative splicing also enables transcription to start
at a gene and then continue transcribing another gene
with another function or encoding a different protein,
located remotely or even on another chromosome [24].
4-5% of DNA, assigned to identified proteins is tran-
scribed in this way.
Mobile or ‘jumping’ genes, were discovered in the
1950s by Barbara McClintock in corn, have also gained
new relevance, one of the reasons being that they can
come under different promoter control resulting in dif-
ferential expression; a process shown to be responsible
for cancerous cell growth [25]. One of the reasons why
genes must be mobile is the compartmentalisation of
gene transcription and the discrete location of genomic
transcription factories, although the exact location of
the latter remains uncertain. This makes movement of
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factories in each cell nucleus is limited. Consequently,
genes located tens of megabases apart or even on differ-
ent chromosomes must move to a transcription factory,
in order to be transcribed [26].
Compartmentalisation of gene transcription, transcrip-
tion-mediated gene fusion and genome-wide transcrip-
tion, [27,28], and the implications of disorder in
proteins [29] for regulation and protein interactions, will
make it difficult for today’s gene networkers to assign a
coding region to a gene in a genome map. However,
without such an assignment, it is problematic to link a
protein to the gene that encodes it.
A further layer of complexity is contributed by
mechanisms, some old, some new, that modify genes
and chromosomes epigenetically [30], without perma-
nently altering the inheritable sequence of the DNA.
Moreover, not only is transcription more complex in
eukaryotes and metazoa than in prokaryotes, the same
holds for the translation of the message and its regula-
tion. In recent years, we have learned that non-coding
DNA [7] encodes small RNAs or micro RNAs [8] which
control gene expression at the level of transcription and
translation in metazoa and humans.
This short summary of the state of current genetics
clearly illustrates that co-linearity of genotype and phe-
notype, of gene and protein, represents a simplistic
interpretation of the situation in eukarya, and is only
one side of the coin. The other problem for systems
biology and proteomics, is the inherent intricacy of the
path from the genetically-determined primary structure
of a protein to its functional structure in the cell.
From Gene to Protein
The optimistic expectation, that the genetically deter-
mined primary structure of a protein contains all the
information required for formation of a unique, three-
dimensional, secondary and tertiary, spatial, three
dimensional structure was widely shared by my genera-
tion of biochemists. This is also what Jacques Monod
had expected [31]. He thought that a protein has only
‘...o n ed e f i n e ds t r u c t u r ea n do n eu n i q u ec o m m u n i q u é . . . ’
and indeed there are examples of where this expectation
holds true.
I. Protein folding, the other half of the genetic code
Pauling’s, [32] perception of the ways and means by
which higher order structures of a protein are formed
from the backbone structure of primary amino acids,
guided Christian B. Anfinsen, [33] in his attempts to
decipher the other half of the genetic code. He could
show that de-natured ribonuclease, with its four -S-S-
bonds reduced, spontaneously refolded into its native
structure, once the denaturing agent, 8 M urea, was
removed by dialysis and the scrambled enzyme exposed
to a small amount of an -S-S- reducing agent, mercap-
toethanol. Under these conditions, disulfide interchange
eventually formed out of a mixture of 105 incorrectly
folded isoforms, a single homogenous product which
was indistinguishable from native ribonuclease. (Rena-
turation is driven by the free energy, ΔG, which is
gained when the unfolded polypeptide chain refolds into
a stable, native structure. The gain in enthalpy offsets
the loss of entropy, when the more ordered, folded
structure is formed).
Further supporting evidence came from the successful
recombination experiments of Frederic M. Richards,
[34], with ribonuclease S, a 20 amino acid fragment, cut
off from the N-terminal half of ribonuclease, and the
remaining core of the enzyme with its 104 residues,
containing all four disulfide bridges of the native, parent
molecule. The small and large fragment recombined
correctly and the structure and function of the native
ribonuclease were completely restored. The experiments
of Frederic M. Richards proved that cooperative, non-
covalent forces are also responsible for protein-protein
recognition and interaction, just as Linus Pauling had
foreseen [32].
Another way to solve the problem of protein folding
rests on the expectation that it should be theoretically
possible to predict the three-dimensional structure of a
protein from the chemical and physicochemical proper-
ties of the constituent amino acid side chains and their
behaviour in aqueous solution. However, although esti-
mates of the forces involved in folding a protein have
been made and continuously refined [35], all these
efforts have been insufficientt op e r m i tr e l i a b l ep r e d i c -
tion of the higher order structures of larger proteins
from their amino acid sequences.
Ribonuclease therefore turned out to be more of an
exception rather than the rule. In many cases, one and
the same protein can assume different conformations
with different functions in the same cellular environ-
ment and location.
In the decades since Anfinsen’se x p e r i m e n t s ,t h e
instruments that help a cell to fold its proteins have
been identified. Anfinsen and his colleagues [33] were
already aware that folding may require assistance,
because renaturation of ribonuclease in vitro took hours,
much longer than the time needed for folding of a poly-
peptide chain of this length in vivo,w h e r ei ti sk n o w n
to occur in about a minute or less. However, when
Anfinsen and his colleagues [36] added an extract con-
taining an enzyme which catalyzes disulfide interchange,
renaturation occurred in vitro as fast as it did in vivo.I n
the meantime, a number of folding partners were dis-
covered, including enzymes which help to form disulfide
bonds and enzymes such as peptidyl prolyl isomerases
which accelerate the cis-trans isomerizations of peptide
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correct placement of disulfide bonds is often rate-limit-
ing in protein folding, notably of proteins which are
secreted. Some secreted proteins, for example trypsin,
chymotrypsin [39] and insulin [40] are formed as inac-
tive precursors, which are converted to the active form,
with the right arrangement of disulfide bonds, by limited
proteolysis. Moreover, cells that secrete proteins harbour
disulfide isomerases that help to promote disulfide inter-
change and rearrangement of proteins to be secreted.
Proteins which are secreted, or those targeted to the cell
surface first enter the luminal space of the endoplasmic
reticulum (ER) where they are properly folded and in
some cases modified, for example, by glycosylation.
Only properly folded and processed proteins can exit
from the ER. Peter Walter and his colleagues, in San
Francisco have studied the regulatory mechanisms in
eukaryotic cells that control folding and secretion of
proteins in the ER [41]. They concluded that in the
event of misfolding, the unfolded protein response of
the cell (UPR) comes into play, which can order the
death of a cell with misfolded proteins by apoptosis.
Folding malfunctions seem to play a role not only in
familial protein folding diseases, but also in diabetes,
cancer, viral infections and prion-based diseases [42].
The discovery and characterization of the heat shock
proteins, such as HSP 60 and HSP 70, helped to gain
new insights into the fate of proteins in the living cell.
These and other chaperones accompany proteins in the
cell from their formation to their degradation and
removal. While without their help, newly folded proteins
would form aggregates, this is only one of their many
essential functions. By 1989, Walter Neupert’s laboratory
in Munich had described a role for a heat shock protein
in the assembly of proteins in mitochondria [43]. Subse-
quently, chaperones were shown to help folding poly-
peptide chains in the course of their synthesis, to
protect already folded proteins and to mark those which
are incorrectly folded for degradation [44,45]. Chaper-
ones may even participate in the folding process itself,
like a folding enzyme [46].
Remarkably, chaperones are not only required for pro-
tein folding, they also help in the assembly of macromo-
lecular complexes such as proteasomes, ribosomes and
spliceosomes. For example, an assembly chaperone has
recently been described that assembles the protein
building blocks of the spliceosome and helps to build
this complex machine in the cell [47,48]. This kind of
chaperones probably assists in the biogenesis of all
macromolecular complexes in the cell. (For more infor-
mation see the review of Hartl, F. U. und Hayer-Hartl,
M. in Science. (2002) [44], and the publication dealing
with cellular functions of molecular chaperones,i n :
Mechanisms of Protein folding [49]).
Despite the significant body of knowledge that has
accumulated relating to the mechanism of protein fold-
ing in the living cell, reliable folding of larger complex
proteins in the laboratory remains to be achieved. As we
learn more about ligand-induced conformational
changes of proteins [50], it is becoming clear that the
cause of our failure might be the ease with which some
proteins are capable of changing their structure and
function. Thus, the genetically-determined primary, back
bone structure of a protein can in some cases form dif-
ferent higher order structures. This process is not only
induced by binding of ligands, which regulate and deter-
mine the functionally-relevant actions and interactions
of such proteins in the cell, because there are also
intrinsically disordered proteins or parts of proteins.
Flexible Proteins
Although Linus Pauling [51] had to abandon his instruc-
tive theory of antibody formation, his notion of a flex-
ible secondary and tertiary structure of antibody binding
sites in particular, and of proteins in general, has been
vindicated.
I. The antibody: an example of a flexible protein
Today, there is convincing evidence that antibody bind-
ing sites can accommodate structurally different haptens
or antigens [52-54]. For example, a monoclonal antibody
raised against the HIV-1p24 protein can bind to several
unrelated peptides [55]. James, Roversi and Tawfik [56],
from the Weizmann Institute in Rehovot have demon-
strated that a monoclonal antibody, specific for a 2,4
dinitrophenyl (DNP) hapten also bound, with a broad
range of affinities, to several, unrelated aromatic com-
pounds and even to a protein. Adaptability of the anti-
body binding sites is also in agreement with different
crystal structures of the same antibody, unbound and
bound to a hapten. A fragment, Fv, of the variable bind-
ing site of this monoclonal antibody did crystallize, in
the absence of the ligand, in two different, stable confor-
mations and in complexes with aromatic haptens and
with a proteinaceous antigen, it adopted a third and a
fourth conformation [57]. Fig:1.
An antibody clearly illustrates the flexibility of a pro-
tein and the unpredictability of the structure-function
relationship [58]. Thus, a monoclonal antibody exists in
solution as an ensemble of isomers, each capable of
binding a structurally-different ligand. The plasticity of
antibodies is exploited in current medicine, notably of
camelid antibodies (antibodies of camels), which are
homologous to human VH, variable heavy antibody
chains, and possess a simpler structure than other anti-
bodies. Whether structural changes are limited to a spa-
tial rearrangement of contact residues for the ligand in
the antibody binding site, or are propagated allosterically
to other parts of the antibody molecule remains to be
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vation enthalpies for binding hapten or antigen, is
inclined to assume that hapten-binding leads to a large,
long-range, conformational transition of the whole
antibody.
II. Receptors are examples of flexible proteins,
demonstrating the advantages of structural plasticity and
functional versatility for regulatory proteins
In the first sentence of the preface of his unsurpassed
treatment of allosterism, Max Perutz praised the versati-
lity of proteins [60]: ’In the popular view the structure of
DNA has told us all about the molecular basis of life,
but in fact DNAs and most RNAs are chemically inert,
whereas proteins are the workhorses of the living cell.
They function as catalysts and genetic regulators, pumps
and motors, receptors and transducers, stores and trans-
porters, scaffolds and walls, toxins and antitoxins, con-
ductors and insulators, and much more’.
Aside from antibodies, receptors are prime examples
of ligand-induced adaptability of structure and func-
tional versatility. However, receptors also exemplify the
functional advantages of structural plasticity and func-
tional versatility. Some receptors can bind different
ligands and perform different actions. Promiscuity of
ligand coupling is biologically important, because it
enables, for example, one and the same cytokine to
cross-talk to different receptors, thus allowing one and
the same cytokine to control different biological path-
ways. This considerably enlarges the signalling repertoire
of a given cytokine.
Receptors are proteins engaged mostly in signal trans-
fer from the outside to the inside of and between cells
[61]. Aside from receptors in the plasma membrane of
cells, there are receptors bound to intracellular bound-
aries, to mitochondrial and nuclear membranes. Nuclear
receptors transmit signals from steroid and non-steroidal
hormones such as thyroid hormones and retinoic acids,
which can pass through the plasma membrane. Finally,
pathogenic microbes [62] may transfer their receptors
into cells, making them susceptible to infection [63].
Like receptors, receptor ligands have many diverse
structures and functions acting as sensory signals, odor-
ants and photons, hormones, growth factors, cytokines
and chemoattractants, and much more. Ligands may be
as small as a photon or as large as a protein, such as
insulin. In some cases, the interaction with ligands
causes a structural transition of the receptor, which trig-
gers tyrosine phosphorylation. Some receptors have
intrinsic tyrosine kinase activity and phosphorylation
sites on the cytoplasmic side of the receptor chains,
others recruit tyrosine kinases when activated and, in
other cases, activation of a receptor and signalling
requires the recruitment of a co-receptor.
Robert M. Stroud and James A. Wells [64] draw the
distinction between two kinds of receptors. In one kind,
ligand-induced structural changes bring about lateral
association of separated subunits in the membrane, lead-
ing to dimerization or oligomerization of the receptor.
In the other kind, structural changes are confined to a
re-arrangement of a pre-existing polymeric assembly.
Stroud and Wells have named receptors belonging to
the first group, horizontal receptors and those belonging
to the latter group, vertical receptors. Though I have
adopted their classification here, there are some recep-
tors that do not fit into their scheme. Fig: 2 and Fig:3.
Horizontal receptors bind mono-or multimeric protein
ligands. This kind of receptors control gene transcrip-
tion and translation and regulate cell replication, growth
and cell death. The three-dimensional structures of
almost a dozen complexes of the ligand-binding extra-
cellular parts of these receptors with their ligands have
been solved [65]. Although the structural rearrange-
ments on binding of the ligand differ considerably from
one receptor to the next, as Walter Sebald et al. have
shown [66-68], all horizontal receptors eventually form
dimers or oligomers on ligand binding and activation. A
consequence of receptor oligomerization is the forma-
tion of new interactive surfaces on the inside of the
membrane for coupling partners, mostly components of
intracellular signalling chains. The best-characterized
Figure 1 Binding promiscuity of a monoclonal antibody.O n e
and the same monoclonal antibody has different binding sites for
antigens, each of which can bind to structurally different antigens.
The same antibody has two conformations, 1 and 2. Conformation
1 has binding sites with a shallow groove, which can accommodate
even a protein antigen, (antigen 1). The same antibody can assume
conformation 2 with a deeper binding site, which fits aromatic
haptens, such as a DNP, a dinitrophenyl - hapten, antigen 2.
Antibodies with such flexible, promiscuous, binding sites are in
allosteric equilibrium. This scheme is a simplified version of a
scheme of Foote, J. 2003. Isomeric Antibodies. Science. 229: 1327-
1328) and was first shown with approval of the author and the
AAAS in my forthcoming book in German: <Von Molekülen zu Zellen.
100 Jahre experimentelle Biologie. Betrachtungen eines Biochemikers>.
It is shown here with permission of the GNT Verlag für Geschichte
der Naturwissenschaften und der Technik. Diepholz. Stuttgart, Berlin.
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family of human growth hormone receptors (hGHRs).
The structural flexibility and coupling versatility of both
receptor and ligand is startling. The same structures in
human growth hormone can bind to different receptors
[69], and, vice versa, hGH receptors can use the same
structural elements for binding structurally different
ligands.
Consisting of a modular structure and accepting both
intra-and extra-cellular signals, the integrins constitute
another group of horizontal receptors with remarkable
structural pliability and functional versatility. Upon
phosphorylation by tyrosine kinases, the tails of integrins
bind specifically to muscle proteins such as talin, and
transmit signals to the submembranous cytoskeleton
[70,71], whereas the extracellular domain of integrins
binds to constituents of the extracellular matrix. In this
way, integrins modulate cell-cell interactions [72] and
play a central role in cell-cell adhesion.
The largest family of receptors is the species of seven
transmembrane, heptahelical, receptors, coupled to G
proteins, (G = GTP-binding). One cannot assign these
receptors unequivocally to the vertical receptor class,
because there is increasing evidence of oligomerization
of G-protein-coupled receptors [73]. These receptors are
ubiquitous: they are found in the cell membranes of
archeae, halobacteria and metazoa, as well as plants,
mammals and humans. Rhodopsin, located in the retina
of the eye, which is activated by light [74], bacterio-rho-
dopsin [75], opsin [76] and the ß2-adrenergic receptor
[77] also belong to this group. These are currently the
best characterized receptors at the structural level and
are also targets of modifiers and inhibitors with impor-
tant therapeutic value in medicine, particularly
Figure 2 Key characteristics of horizontal and vertical receptors. The differences in structural changes on activation by binding the ligand
are indicated schematically. The striking feature of horizontal receptors is that they associate and form dimers or multimers upon activation,
whereas activation of vertical receptors does not involve quaternary structure changes of the already associated, preformed oligomer. This figure
was originally reproduced from R.M. Stroud and J. A. Wells. 2004. Mechanistic Diversity of Cytokine Receptor Signalling across Cell Membranes,
and the journal, Science STKE.2004.Re: 7, pps: 1-17, with approval of the authors and the AAAS in my forthcoming book in German: <Von
Molekülen zu Zellen. 100 Jahre experimentelle Biologie. Betrachtungen eines Biochemikers>. It is shown here with permission of the GNT Verlag für
Geschichte der Naturwissenschaften und der Technik. Diepholz. Stuttgart, Berlin.
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phorylation-cascades and cell metabolism. One way, but
not the only way, to transmit signals from these recep-
tors after activation is through G proteins. For more
information, see [19,78-80] and the recent excellent
review by Ilka Böhme and Annette G. Beck-Sickinger in
this journal [81].
The flexibility and functional versatility of antibodies
and receptors raise the question of how a protein must be
designed in order to be able to drastically change its struc-
ture and function on binding ligands. New insights into
the dynamics and physicochemical properties of some
proteins may help to answer this question. The dynamics
of proteins may also explain why protein-folding in vitro
has turned out to be such an intractable problem.
Internal Dynamics of Proteins
Figure 4 lists examples of processes in which protein
dynamics play a role. Hans Frauenfelder [82], a pioneer
in the field of protein physico-chemistry, described the
dynamics of a protein, myoglobin, as early as the 1970s.
According to Hans Frauenfelder et al., [83], some pro-
teins are an assemblage of conformational variants
which move in an intricate, multidimensional energy
landscape and interconvert from one structure to
another in tens of femtoseconds (A femtosecond is 10
-15
sec) or hours. A detailed analysis of the temporal order
o ft h ec o n f o r m a t i o n a lc h a n g e sm a ye v e n t u a l l ys h e d
more light on the topography of the energy landscape
and explain the properties of these proteins [84]. Since
individual molecules may follow different paths, single-
molecule methods are now increasingly used. Analysis
of this intricate problem is being actively pursued and
progress in numerical simulations is already permitting
increasing complexity to be handled [85,86].
NMR spectroscopy, has also provided structural infor-
mation on proteins exhibiting internal dynamics [87-89].
(For a review see: [[90]). For example, Eisenmesser et al.
Figure 3 Illustration of the variety of different multimeric assemblies of horizontal cytokine-receptors on ligand binding and
activation. hGH = human growth hormone. EP0 = erythropoetin. GCSF = Granulocyte Colony-stimulating factor. FGF = Fibroblast growth factor.
IL-4 = Interleukin 4. TNF = Tumour necrosis factor. This figure is originally reproduced with permission of the authors R. M. Stroud and J. A. Wells
(2004) and the AAAS from <Mechanistic Diversity of Cytokine Receptor Signalling Across Cell Membranes>, and the journal, Science STKE.2004.Re: 7,
pps: 1-17, and is shown in my forthcoming book in German: <Von Molekülen zu Zellen. 100 Jahre experimentelle Biologie. Betrachtungen eines
Biochemikers>. It is reproduced here with permission of the GNT Verlag für Geschichte der Naturwissenschaften und der Technik. Diepholz.
Stuttgart, Berlin.
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cyclophilin A, on going from a non-active to a catalyti-
cally active state. (Cyclophilins are prolyl isomerases,
that are inhibited by cyclosporin [93]). Eisenmesser
et al. observed that during catalysis some amino acids
can change their position as fast as the elementary steps
of the catalytic reaction, suggesting that conformational
changes of the enzyme are synchronized with catalysis.
However, surprisingly, identical structural changes also
occur in the non-active enzyme. The only difference
between the active and inactive enzyme is that the sub-
states are differentially populated. One might speculate
Figure 4 Examples of processes involving protein dynamics. From the top row: (1) Conformational changes between folded and unfolded
states, (2) ligand receptor interactions, (3) a representation of the effects of covalent modification of a protein, (4) the role of phosphorylation,
(P), in stabilising one of several interconvertible forms and finally (5) transitions between structural sub-states of enzymes, on going from an
inactive to an active, substrate-bound state are shown. The double arrows connect the interconvertible states with the longer arrows indicating
the energetically favoured direction of the change. Percentages, where listed, give rough estimates of how much each state is populated. This is
a simplified version of the scheme of Yuanpeng J. Huang and Gaetano T. Montelione (2005). News and views: Structural Biology: Proteins flex to
function. Nature, 438, 36-37. It was reproduced with approval of the authors and Macmillan Publishers Ltd. in my forthcoming book in German:
<Von Molekülen zu Zellen. 100 Jahre experimentelle Biologie. Betrachtungen eines Biochemikers>, and is shown here with permission of the GNT
Verlag für Geschichte der Naturwissenschaften und der Technik. Diepholz. Stuttgart, Berlin.
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Page 8 of 15that proteins with an intrinsic plasticity such as
cyclophilin A may have been earmarked by evolution to
become enzymatic catalysts, because all the structural
prerequisites for catalysis are already present in the
non-active protein.
Another protein, for which a comprehensive range of
NMR data are available is human ubiquitin, a relatively
small protein of 76 amino acids. The native state of ubi-
quitin was described [94] as an ensemble of different
conformers, interconverting on a picosecond to nanose-
cond scale. The mobility of the structure of this protein
is not restricted to its surface loops and side chains, it
also includes its core, which was described as liquid-like
and fluctuating [95,96]. It is remarkable that changes
including mutational changes, leading to a complete
redesign of its hydrophobic core do not compromise the
structural integrity of this protein. According to Martin
K a r p l u sa n dh i sc o l l e a g u e s[ 9 7 ] ,s u c hp r o p e r t i e sm a y
even be representative of proteins in general.
The bewildering variety of conformational sub-states
of some proteins is an indication of their structural plas-
ticity and versatility of function. We are just beginning
to understand what makes some proteins flexible and
what kind of forces drive structural transitions. The
extraordinary malleability of this kind of proteins is also
of great interest for protein engineers trying to redesign
proteins in the laboratory.
The progress in structural analysis and, particularly,
NMR spectroscopy, has significantly extended our
insight into co-and post-translational modifications in
the last decade, a theme which has already been
reviewed exhaustively in recent years [29,98,99]. In this
context, it suffices to say that the diversity and versatility
of structural disorder of proteins and of protein modifi-
cations, in addition to the consequences of rRNA and
mRNA splicing, has greatly increased the repertoire of
possible protein structures and functions, way beyond
the information deducible from the genome. Disorder in
proteins has important consequences, notably for the
function of regulatory proteins, but also for protein
interactions in the cell. It remains to be seen to what
extent systems biology and proteomics will be able to
handle the structural and functional versatility of pro-
teins, notably of proteins carrying out regulatory
functions.
In conclusion, structural flexibility seems to be an
inherent property of some, if not all, proteins. It allows
versatility of function and is essential for regulation.
Such properties can not be deduced from the genetic
readout, from the primary back bone structure of these
proteins. Moreover, in many cases, regulated proteins
can change their structure and function in the cell as a
consequence of reversible covalent modifications, such
as by phosphorylation and/or other changes. About 2%
of human genes encode protein kinases and phospha-
tases. Such reversible modifications also leave no traces
in genetic readouts.
Another aspect that cellular biochemistry must deal
with is the role of the environment. Compared with
hemoglobin and other water soluble, allosterically,
ligand-regulated proteins, the information on structural
transformations of membranous receptors on ligand-
binding and activation is limited. The reason is that
receptors are embedded in a water-lipid interface. This
makes it difficult to isolate them in a native conforma-
tion and identify the structures of the active conformers
at high resolution. Therefore, the structural information
at hand often encompasses only the water soluble extra-
cellular part of the receptor, and does not allow assign-
ment of specific roles in signal transmission to reactive
interfaces on the cytosolic side, which are exposed to
the cell’s interior, where coupling with signal transmit-
ters occurs. (Notable exceptions are the heptahelical
G-protein coupled receptors).
The role of the environment
Although I shall concentrate here on the role of the
membranous environment for receptor structure and
function, the influence of the environment on actions
and interactions of proteins, deserves, of course, serious
consideration in all cases, because environmental influ-
ences on structurally variable proteins are not restricted
t ot h em e m b r a n ea n da r em o s tl i k e l ya l s or e s p o n s i b l e
for configurational rearrangements of proteins in other
cellular environments.
How can the membranous environment affect recep-
tor structure and function? [100]. The membranous
environment may affect receptor activation and de-acti-
vation, signal transduction and receptor re-cycling in
many ways [101]. Membrane lipids could either influ-
ence receptors through global changes in the physical
state of the water lipid bilayer, for example through
microviscosity changes, or individually through discrete
and specific interactions. While, the former is unlikely
in homoiothermic animals, the latter is to be expected.
Although, the central importance of this problem is
widely recognized, we still do not have enough data on
the physicochemical restraints that individual membrane
lipids may exert on the mobility and reactivity of pro-
teins embedded in the membrane. An example is the
role that is being attributed to complexes, or transduci-
somes, containing whole signal transmission chains,
arranged on lipid scaffolds in the membrane [102,103].
Although, this is undoubtedly an attractive perspective,
the role of lipids in forming and maintaining such
transducisomes in membranes is not yet clear. We
neither know the composition, size or the lifetime of
such lipid-protein complexes [104].
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Page 9 of 15Although, it is evident that the behaviour of proteins
at the water-lipid interface is difficult to study, I also
recall that for the older generation of biochemists, the
lipid bilayer was mostly a undefined mixture that is bet-
ter circumvented. For example, Carl F. Cori, [105], one
of the great biochemists of the 20
th century, with whom
I had the privilege to work with in the 1950/60s,
although finally accepting a role of insulin in making
the membrane permeable for sugars [106], insisted that
an intracellular enzyme, glucokinase or hexokinase,
rather than a membrane-bound insulin receptor activat-
ing a membranous glucose carrier, controls the uptake
of glucose into muscle.
The increasing awareness of the important role of
the membranous environment in reactions of pivotal
importance for the life of cells, brings hope that in the
future more biochemists will try to decipher the influ-
ence of this particular solvent milieu on the many
important reactions that occur in or at water-lipid
interfaces in the cell. I expect that an important incen-
tive for such greatly needed studies will be the avail-
ability of new methods for in vivo observations,
methods that allow visualization of proteins in their
natural environment and study of their movements
and interactions in situ.
New and old ways of in vivo observation
Already in the 1960s, biochemists of my generation,
notably those who were interested in regulation, were
keen to determine the cellular location of the enzyme
or the protein they were studying. However, cellular
compartmentalisation made any extrapolation of the in
vitro to the in vivo situation speculative and tentative. I
described the situation in 1969 [107]
.: ’Equally as
important as the actual molecular mechanism of allos-
teric transitions which may differ from enzyme to
enzyme, is the in vivo expression of the regulatory poten-
tiality of enzymes which control multienzyme sequences.
The regulatory behaviour of an enzyme in the isolated
state can only serve as a guide which may hopefully
lead us to its actual control properties in the living cell’.
At that time, one tried to localize metabolites in cells
by using radioactively labelled 2-deoxyglucose which,
after being phosphorylated to 2-deoxyglucose-6-phos-
phate, accumulates in the cell [108]. Because it can not
be metabolized further, this compound could be loca-
lized by a combination of radioautography and electron
microscopy and from its position in the cell, one could
deduce the location of the kinase which had phosphory-
lated the sugar analogue [109]. Later, receptors were
labelled with fluorescent dyes [107] and their move-
ments in cells studied [110]. Today, the introduction of
ag e n ef o rf l u o r e s c e n ta q u a p o r i ni n t oal i v i n gc e l la n d
its fusion to a gene expressing the protein to be
localized, has led to new and improved methodologies
to monitor a protein and visualize its position in the
intact cell [111,112]. Roger Tsien’s methods in conjunc-
tion with other physical methods, such as fluorescence
energy transfer, FRET, fluorescence recovery after
photobleaching, FRAP, and fluorescence correlation
spectroscopy with single molecule detection, [113],
today allow the identification and tracking of an
increasingly wide range of molecules, both large and
small, in their natural environment. The introduction of
new and refinement of older methods has already
brought us a wealth of new and valuable information
on receptor function in living cells [114-116]. In the
future, the aim is to enlarge the number of proteins
that are visualized until one gets a movie,s h o w i n g
movements and interactions of all kinds of proteins in a
living cell [117].
Spectacular advances have also been made in optical
microscopy by Stefan W. Hell in Göttingen [118,119].
Until now, the Abbe diffraction barrier of optical micro-
scopy limited the resolution of conventional light micro-
scopy to 200 to 300 nm in lateral dimensions, leaving
many intracellular organelles and molecular structures
unresolvable, thus limiting the use of microscopy for
three-dimensional imaging of biological structures. Now
however, the Abbe diffraction limit has been trans-
cended, and resolutions of 20-30 nm and 50-60 nm in
the lateral and axial dimensions respectively have been
achieved. With new techniques [120], such as stochastic
three-dimensional optical reconstruction microscopy,
STORM, a resolution can be obtained which enables the
visualization of cellular structures by light microscopy in
three dimensions.
Equally impressive are the advances in recent years
in the development of cryoelectron microscopy and
cryoelectron tomography. Following the pioneering
work in the 1960s of De Rosier and Aaron Klug, cryoe-
lectron tomography is now beginning to allow to make
visible complex molecular assemblies within a living
cell, such as actin bundles, intermediate filaments,
which build the scaffold of a cell. Moreover, one can
monitor proteins and nucleic acids on ribosomes, the
cellular sites of protein synthesis [121,122]. In the
future, all will depend on how far one will be able to
increase the resolution, which is still in the tenth nm
range.
Attempts are also being made today to study the
structure of proteins in the living cell by in cell NMR
spectroscopy [123,124]. This might be the beginning of
a new era of structural analysis of proteins in situ.
Another technical development that deserves attention,
is the application of high resolution scanning X ray dif-
fraction microscopy, or SXDM, to in situ objects
[125,126].
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The chances of today’s functional genetics and
proteomics
Today, it is agreed that a functional assignment of the
genome is needed [127]. For that purpose, the ENCODE
project, ENCyclopaedia Of DNA Elements) [128], which
should provide functional assignments to all genes in
the human genome has been organized and implemen-
ted. The most advanced sequencing techniques, com-
bined with the most sophisticated computational
methods are being applied. A pilot study, covering 1%,
or 30 megabases, of the human genome, showed that
nearly all of the DNA in a human chromosome is tran-
scribed into RNA, as well as revealing the existence of
many, still unrecognized, stretches of DNA with as yet
unknown functions.
Another objective lies in finding out how the expres-
sion of DNA, packed in the chromatin of the chromo-
some, is regulated and epigenetically controlled. This is
as i g nt h a ti nt h ef u t u r e ,i na d d i t i o nt oa l lt h ee f f o r t s
aiming at a functional definition of the genome, one will
also take into account the bewildering and still growing
number of ways and means of how the genetic readout
is modified, controlled and regulated. Depending on
how cell-specific gene expression is, one might even
have to identify the functional role of genome sequences
in individual, differentiated cells.
Stefan Bornholdt, [129], has pointed out that going
from measurements of all the factors, including all regu-
latory factors, that are responsible for the expression of
a single gene, to measurements of the same parameters
controlling the expression of hundreds and thousands of
genes in a gene network, would make the number of
differential equations that have to be solved to describe
such a realistic situation intractably large, at least for
the time being. But, mathematical integration is neces-
sary to handle large amounts of data and model com-
plex biological systems. Such concerns are realistic, and
have also been raised by the physicist and evolutionary
biologist, Alfred Gierer [130]. Thus, it seems that today’s
systems biology must, like Odysseus, guide its ship with
care and imagination, avoiding the perils of Scylla and
Charybdis. On the one hand, large amounts of data are
necessary to describe complex biological processes in
living systems and on the other, it may turn out that the
use of this plethora of data is limited by the availability
of algorithms capable of integrating them. This will be a
difficult problem to solve for mathematicians and com-
puter specialists.
The relationship between system complexity and the
present modelling possibilities is shown in Fig: 5.
The obvious way to deal with such immense complex-
ity, is simplification and reduction, although there are
cogent reasons for which one has had to turn, for exam-
ple, from single genes to gene networks, because dele-
tions or mutations of single genes often have no
discernible effect on the cell. For the time being however,
I do not see any other way. However, here again a word
of caution is warranted: for any kind of reduction, the
question is of course how far can one reduce a complex
biological process, without losing characteristic features?
There are different ways to reduce complexity. One pos-
sibility is to choose a simple object. This is exemplified
by Sidney Brenner’s [131] introduction and successful
use of Caenorhabditis elegans in genetics. The recent dis-
covery of RNA-interference in Caenorhabditis by Craig
Mello und Andrew Fire [132] demonstrates the value of a
simple experimental object. Although, these experiments
show the value of a suitable model organism for experi-
ments in biology, one should n o tf o r g e tt h a tt h es u c c e s s
of using simple biological objects, depends on the kind of
questions asked.
Another possibility to simplify metabolic and genetic
networks is to focus only on on/off switches and feed-
back loops that control whole systems [133]. Rather
than studying complex sequences of reactions, one con-
centrates on the pacemaker of a chain of reactions. An
example is the control of a chain of metabolic enzymes,
f o re x a m p l eg l y c o l y s i s ,b yas i n g l ee n z y m e ,s e r v i n ga s
pacemaker [134], or the control of many genes in an
operon by a promoter. These stripped down models
may not represent the much more involved dynamics of
the actual system in the living cell, but by comparing
such simplified models with the actual situation in the
cell, one can at least see whether and when, and to what
extent, such binary on/off switch models mimic the
dynamics of the real complex network in the living cell.
For example, such simplified models, could correctly
predict the dynamics of the complex genetic network,
controlling segment polarity in the development of Dro-
sophila melanogaster [135], and a simplified binary
model of the genetic network controlling the yeast cell
cycle [136] realistically modelled the actual situation.
I have commented on some of the problems func-
tional genetics and in situ proteomics will face in the
future. The extent to which the new in vivo experimen-
tal biology of the 21
st c e n t u r yw i l lb ea b l et oh a n d l e
these challenges is yet to be seen. The solution of these
and other problems will depend on whether we shall be
able to handle, both the stochasticity of gene expression
and the complexity of the genetic readout. This requires
large amounts of reliable in vivo data and algorithms,
capable of transforming huge amounts of data into rea-
listic models. Despite all uncertainties and all the pro-
blems that remain to be solved, there is no doubt that a
new era has begun. On the one side, today’ss y s t e m s
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growing information technology, that has already proved
its ability to handle large amounts of data. (Google and
similar search engines are examples). But, systems biol-
ogy and in vivo proteomics also represent a new experi-
mental biology, for which the living cell and its
functions have become research objects. To study pro-
cesses in the living cell, old techniques, such as micro-
scopy have been refined and new techniques developed.
The exponential and continuing progress in the devel-
opment of techniques in the last years, and the opti-
mism in handling complexity [137] make me optimistic
that some, but not all, of the ambitious goals of systems
biology and proteomics may be attained. The new area
today reminds me of the beginnings of cell biology in
the first half of the 19
th century, which the microscope
in the hands of the pioneers of cell biology, of Rudolf
Virchow, [138] and of O. and R. Hertwig, [139,140],
helped to make possible.
In vivo observation of the molecular organisation of
living systems will do away with the persuasive argu-
ment that the insights obtained by biochemists from in
vitro studies are uncertain and tentative, because living
systems can only be observed under conditions in
which their integrity is preserved. This view was shared
by Niels Bohr [141] (1885-1962. Nobel prize for Phy-
sics, 1922), who is probably the best-known example
of a famous physicist interested in biology. (An interest
that may have had its origin in the fact, that his father
was a renowned physiologist). The functions and the
material properties of a living organism were for Bohr
only complementary and could not be derived from
one other, a view still shared today by some chemists
and physicists. Would Niels Bohr still be alive, he
Figure 5 The relationship between system complexity and the present modeling possibilities. Whereas single genes can be modeled in
molecular detail by stochastic simulations, (Top: left side), differential equations are already required for modeling small genetic circuits (centre
left). Midsize genetic networks can at present only be modeled, when simplified, by concentrating on on-off switches, and large genetic
networks are for the time being still out of reach of predictive simulations and modeling. Finally the last row shows that much information is
available in the case of the consequences of the activity of single genes. The available information then gradually decreases from flow patterns
of the activity of gene networks to functional modules of large networks. Activity patterns of large genetic networks are for the time being, still
out of reach of predictive simulations and modeling. This is a simplified version of an illustration which indicates the different complexity of
systems by Stefan Bornholdt, (Stefan Bornholdt, (2005). Less Is More in Modeling Large Genetic Networks. Perspectives: Systems biology. Science
310, 449-451). It is shown with permission of the author and the approval of Macmillan Publishers Ltd., in my forthcoming book in German:
<Von Molekülen zu Zellen. 100 Jahre experimentelle Biologie. Betrachtungen eines Biochemikers>. It is reproduced here with permission of the GNT
Verlag für Geschichte der Naturwissenschaften und der Technik. Diepholz. Stuttgart, Berlin.
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Page 12 of 15would certainly welcome the new in vivo biochemistry
of the 21
st century.
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